Chempartner Pharmatech Set to Add Two Major Shareholders to Roster

MT Newswires Live

12 Sep 2024

Chempartner Pharmatech Set to Add Two Major Shareholders to Roster

Chempartner Pharmatech (SHE:300149) said Liang Yufeng and Yu Xianwen are set to become major shareholders in the pharmaceutical company after Hangzhou Ciyangliangjia Investment Management Partnership transfers its holdings in the company.

Ciyangliangjia Investment Management Partnership holds 51,185,660 shares of the company, or a 10.24% stake, according to a Thursday filing with the Shenzhen bourse.

Following the share transfer, Liang will hold a 5.24% stake and Yu will hold a 5.00% stake in Chempartner Pharmatech.

Price (RMB): Â¥4.64, Change: Â¥-0.020, Percent Change: -0.43%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2466228141"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2466228141\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2466228141?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-12 16:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2466228141","market":"fut","top_or_hot":-1,"title":"Chempartner Pharmatech Set to Add Two Major Shareholders to Roster","media":"MT Newswires Live","content":"<html><body><p>Chempartner Pharmatech Set to Add Two Major Shareholders to Roster</p><p> Chempartner Pharmatech (SHE:300149) said Liang Yufeng and Yu Xianwen are set to become major shareholders in the pharmaceutical company after Hangzhou Ciyangliangjia Investment Management Partnership transfers its holdings in the company.</p><p>Ciyangliangjia Investment Management Partnership holds 51,185,660 shares of the company, or a 10.24% stake, according to a Thursday filing with the Shenzhen bourse.</p><p>Following the share transfer, Liang will hold a 5.24% stake and Yu will hold a 5.00% stake in Chempartner Pharmatech.</p><p>Price (RMB): Â¥4.64, Change: Â¥-0.020, Percent Change: -0.43%</p></body></html>","source":"mtnewswires_live","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chempartner Pharmatech Set to Add Two Major Shareholders to Roster</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChempartner Pharmatech Set to Add Two Major Shareholders to Roster\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-12 16:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Chempartner Pharmatech Set to Add Two Major Shareholders to Roster Chempartner Pharmatech (SHE:300149) said Liang Yufeng and Yu Xianwen are set to become major shareholders in the pharmaceutical ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0077","symbol_name":"质押式回购","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2466228141","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2466228141","pubTimestamp":1726130580,"columns":[],"sourceInfo":{"source_id":"mtnewswires_live","name":"MT Newswires Live"},"weMediaInfo":null,"summary":"Chempartner Pharmatech Set to Add Two Major Shareholders to Roster Chempartner Pharmatech (SHE:30014","collect":0,"end_time":0,"defaultTopTitle":"mtnewswires.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"300149":"睿智医药","BK0077":"质押式回购","SHE":"SPDR MSCI USA Gender Diversity ETF","BK0216":"研究试验"},"translate_title":"Chempartner Pharmatech将在名册中增加两名主要股东","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300149":1,"SHE":1},"content_text":"Chempartner Pharmatech Set to Add Two Major Shareholders to Roster Chempartner Pharmatech (SHE:300149) said Liang Yufeng and Yu Xianwen are set to become major shareholders in the pharmaceutical company after Hangzhou Ciyangliangjia Investment Management Partnership transfers its holdings in the company.Ciyangliangjia Investment Management Partnership holds 51,185,660 shares of the company, or a 10.24% stake, according to a Thursday filing with the Shenzhen bourse.Following the share transfer, Liang will hold a 5.24% stake and Yu will hold a 5.00% stake in Chempartner Pharmatech.Price (RMB): Â¥4.64, Change: Â¥-0.020, Percent Change: -0.43%","kind":"live","is_publish_news":false,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}